NASDAQ · PETS

PetMed Express, Inc.

$1.99 -$0.06 (-2.93%) 1D Market open

Key Metrics

$43.81M
Market cap
P/E · TTM
$179.02M
Revenue · TTM
−$57.29M
Net income
EPS · TTM $-2.81
Dividend yield 0.0%
Free cash flow −$33.01M
Beta · 1Y 1.25
EBITDA · TTM −$47.97M
Gross margin 28.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    Money has been moving out of its sector (Consumer Discretionary).

    Consumer Discretionary has run -5.7 points vs SPY over four weeks, ranking 3→5→10→11 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 23
    A material event was filed (Form 8-K).

    8-K - PETMED EXPRESS INC (0001040130) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 5
    From its Jan 29 high, the share price fell 48%.

    Peak close $3.23 on Jan 29; trough close $1.68 on Jun 5. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -48%
  • Jun 3
    The stock moved -16.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 3
  • Feb 13
    The stock moved +8.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 13

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$43.81M
Enterprise value
Shares outstanding21.4M
52-wk range$1.57 – $4.10
Avg volume · 20D503.1K
Net cash
Book value / share$1.42
IndustryRetail-Drug Stores And Proprietary Stores
ExchangeNASDAQ
About PetMed Express, Inc.
IPO dateSep 17, 1997
Employees189

PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.24
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 28.1%
Operating -32.0%
Net -32.0%
FCF -18.4%
ROE / ROIC -100.4% · -761.0%

Financial Health

Current ratio0.84
Quick ratio0.58
Debt / equity
Debt / EBITDA
Net cash
Working capital−$8.47M

Cash Flow · TTM

Operating CF −$28.39M
Capex −$4.62M
Free cash flow −$33.01M
Buybacks
Dividends paid $21.00K
Shareholder yield 0.0%

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

0.4
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings